Objective: The cytokine/chemokine network is used by the innate and adaptive immune system to orchestrate effective immune responses. Here, we describe the cross-sectional association between cytokine levels and stage of HIV infection to gain novel insights into HIV-1 immunopathogenesis and identify novel therapeutic targets.
Introduction
Persistent inflammation during HIV-1 infection has been associated with accelerated disease progression, endorgan diseases and increased mortality [1] [2] [3] and is reflected by increased levels of cytokines/chemokines in blood plasma [4] [5] [6] . Similarly, the cytokine/chemokine network in genital secretion reflects the functional status of immune cells in the genital tract, where the key events related to genital HIV shedding and sexual transmission occur [7] [8] [9] [10] . In comparison with other body fluids, semen is enriched with several cytokines/chemokines [in particular interleukin (IL)-7 and transforming growth factor (TGF)-b], reflecting the unique immunological features of the male genital tract even in immunocompetent individuals [7] [8] [9] 11, 12] . In HIV-infected individuals, several cytokines/chemokines are further upregulated in genital secretions [8, 9, 13, 14] , which in turn, can favor HIV transmission by promoting local HIV replication and dissemination [15] .
HIV-1 infection does not only affect the absolute levels of individual cytokine/chemokine, but also reorganizes the cytokine/chemokine networks, establishing new strong correlations between various cytokines and thus imposing a high level of rigidity to the cytokine/chemokine network [16] . This phenomenon, which has been described both in blood and semen, is likely to reflect a reduced ability of the immune system to respond to microbial challenges and might affect the transmission of different sexually transmitted infections (STIs), including HIV-1 itself [16] .
Although changes in levels of individual cytokine/ chemokine during HIV-1 infection have been previously described [8, 9, 12] , we sought to assess for the first time the cytokine network in the blood and seminal plasma of men with different stages of HIV-1 infection as well as the effect that antiretroviral therapy (ART) might have on these cytokine levels.
To address this question, we characterized the cytokine/ chemokine network in four groups of men: HIVuninfected individuals; untreated early HIV-infected individuals [sampled within 90 days from estimated date of infection (EDI)], untreated late HIV-infected individuals (sampled more than 90 days after EDI), and ART-treated HIV-infected individuals with undetectable HIV RNA levels in blood (<50 copies/ml).
Methods

Study population
A total of 252 paired semen and blood samples were included in this study from 40 HIV-uninfected men (group 1), and 116 HIV-infected ART-naive participants from the San Diego Primary Infection Cohort (SD-PIC). In the SD-PIC cohort, the EDI was characterized using well defined stepwise rules on the basis of serologic and virologic criteria [17] (Supplemental Table 1 , http:// links.lww.com/QAD/A830). Based on such criteria, we identified 42 untreated early HIV-infected individuals (sampled <90 days from EDI; Fiebig stages 1-5, group 2) and 74 untreated late HIV-infected individuals (sampled >90 days from EDI; Fiebig stage 6, group 3). Additionally, we included 96 ART-treated chronically HIV-infected study participants from the California Collaborative Treatment Group (CCTG)-592 Study with completely suppressed HIV RNA in blood plasma (<50 copies/ml) (group 4). Paired blood and semen samples were collected at the time of study enrollment. Potential infection from Neisseria gonorrhoeae and Chlamydia trachomatis were tested from urine, using transcription-mediated amplification (Aptima, Gen-Probe, San Diego, California, USA). The studies were conducted with appropriate written individual consent and were approved by the Human Research Protections Program at the University of California San Diego, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, and the University of Southern California.
HIV-1 RNA and cytokine/chemokine quantification HIV-1 RNA levels were measured in seminal plasma as previously described [18] . Levels of 31 cytokines/ chemokines were measured in blood and seminal plasma using a multiplex-bead-array assay as previously described [8] (see supplementary data, http://links.lww.com/ QAD/A830). The NIH laboratory that performed luminex measurements is part of the Microbicide Quality Assurance Program (MQAP) [19] .
Statistical analyses
Statistical analysis was performed in SAS v9.2. Cytokine levels were reported as continuous variables by median and interquartile ranges. Comparisons between all groups for difference of medians were done by the Kruskal-Wallis test. Comparisons between pairwise groups were done using the Mann-Whitney U-test. P values for pairwise comparisons were adjusted for multiple comparisons using the Benjamini-Hochberg method (resulting in a raw P < 0.0002 as a cutoff for statistical significance).
Results
Study participants' demographics and clinical data
Detailed characteristics of each cohort are described elsewhere [18, 20, 21] and summarized in Table 1 . All HIV-infected men and 67% of the HIV-uninfected men had sex with other men as their main HIV risk factor. As we did not find any significant differences in general demographics and cytokine levels between MSM and heterosexual men in the HIV-uninfected group, we combined them into one group (group 1) for the purpose of this analysis.
Regarding bacterial STIs, five of our participants were positive by nucleic acid testing at the time of sample collection. This includes one case of chlamydia in the HIV-negative cohort and in the ART-treated group Comparisons between pairwise groups were done using the Mann-Whitney U-test. P values for pairwise comparisons were adjusted for multiple comparisons using the Benjamini-Hochberg method (resulting in a raw P < ¼ 0.0002 as a cutoff for statistical significance). (CCTG) and three cases of chlamydia/gonorrhea in the HIV-infected untreated group (SD-PIC).
Cytokine/chemokine network in blood plasma of the studied groups First, we compared median levels of each cytokine/ chemokine in blood plasma between the four groups described above. We found that five of the 31 measured cytokines [MCP-1, macrophage-inflammatory protein (MIP)-1a, monokine induced by gamma interferon (MIG), interferon-inducible protein (IP)-10, and interferon-inducible T-cell alpha chemoattractant (I-TAC)] were significantly upregulated in blood plasma of group 2 compared with group 1 (Fig. 1a ; Supplemental Table 2 , http://links.lww.com/QAD/A830). These cytokines were all mediators of innate immunity, inflammation and chemotaxis. The extent of the upregulation ranged between 2.4 and 23.4 times with I-TAC, MIP-1a, and IP-10 being the most upregulated (respectively 9.3, 22.3, and 23.4 times). In group 3, IL-18, in addition to the five previously mentioned cytokines, was upregulated in blood plasma compared with group 1 (Fig. 1b ; Supplemental Table 2 , http://links.lww.com/QAD/A830). The extent of the upregulation of these six cytokines ranged between 2.3 and 16.9 with MIP-1a, IL-18, I-TAC, and IP-10 being the most upregulated (respectively 4.6, 4.6, 8.5, and 16.9 times). None of the 31 measured cytokines was significantly different in blood plasma between group 2 and group 3 (Supplemental Table 2 , http://links.lww. com/QAD/A830).
Despite complete suppression of HIV-1 viral replication (<50 copies/ml), ART initiation did not normalize the cytokine network in blood plasma but rather expanded the panel of cytokines that were modulated compared with HIV- To further evaluate the effect of ART initiation on the cytokine network, we also compared cytokines levels between group 3 and group 4, and we observed that 13 cytokines belonging to three distinct groups of cytokines were significantly different between these two groups (Fig. 1d) . A total of 10 out of these 13 cytokines were downregulated in ART-treated (group 4) compared with 
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Compartmentalization of the cytokine/ chemokine network in blood and semen
Previous studies suggest that cytokine/chemokine profiles are different in blood and semen of healthy individuals and that these differences are greater in HIV-1 individuals [8, 9, 12] . Figure 3 displays the compartmentalization of each cytokine, by evaluating the ratio between levels of cytokines measured in seminal plasma versus blood plasma. Ratios for IL-17, IL-33, GM-CSF and IL-13 in which median levels remained under the limit of detection either in blood or seminal plasma were not reported (see supplementary figure 1 ).
We found that levels of all cytokines but five (i.e. IL-18, RANTES, eotaxin, IL-10, and IL-16) were significantly higher in semen than in matching blood samples of uninfected individuals. Cytokines or chemokines, such as IL-1a, IL-8, MIG, IP-10, I-TAC, MIP-3a, GM-CSF, TGF-b, IL-7, and GRO-a were up to 100-fold more concentrated in semen than in blood. These cytokines are distributed across all four categories of cytokines (i.e. mediators of innate immunity, inflammation and chemotaxis; mediator of hematopoiesis, anti-inflammatory cytokine; mediators of lymphocytes activation, proliferation, and differentiation), suggesting that higher concentration of cytokines in semen compared with blood is a general phenomenon and not linked to a specific subset of cytokines.
Generally, whether each given cytokine was more concentrated in blood or in semen, the occurrence of HIV-1 infection did not significantly affect its compartmentalization status between blood and semen (see supplementary figure 1 ). However, for a subset of four cytokines (IL-18, IL-22, IL-12, and IFN-g) that were equally present in blood and semen of HIV-uninfected men (ratio ¼ 1), we observed a shift towards compartmentalization in case of untreated HIV infection, with a relative increase of IL-18 in blood plasma (ratio ¼ 0.2) and a relative increase of IL-22 and IFN-g in seminal levels (ratio>1). For IL-12, we observed enrichment in blood during the earliest phase of HIV infection (group 2) but a relative increase in seminal plasma in subjects with late HIV-1 infection (group 3).
With the exception of IL-12 and TNF-a, we did not observe any significant difference in the seminal to blood ratios between group 2 and group 3. On the other hand, the group of HIV-infected subjects on suppressive ART showed a relative increase in seminal levels for several cytokines compared with untreated HIV-infected and HIV-uninfected controls, including IL-6, IL-22, lactoferrin, MIP-1b, IL-2, IL-15 and GRO-a ( Fig. 3) .
To evaluate the effect of bacterial STIs, we repeated this analysis after excluding five participants who tested positive for chlamydia or gonorrhea. There were no significant changes in the cytokine's levels in blood and semen for the overall comparisons.
Discussion
Cytokines and chemokines coordinate the host inflammatory response to infectious agents by modulating complex cell functions (i.e. cellular 'activation', migration, phagocytosis and antigen presentation). In this study, we evaluated the expression profile of selected mediators of immunity in blood and semen, providing new insights into how the cytokine/chemokine network is organized in HIV-uninfected individuals and how this network is altered during the course of HIV-1 infection and after ART initiation.
In agreement with previous smaller studies, we found that semen and blood are two distinct immunological compartments [8, 9, 12] . Indeed, in healthy HIV-uninfected individuals, the cytokine profile was very different in seminal and blood plasma, with semen being enriched in several pro-inflammatory cytokines and chemokines (mainly IL-1a, IL-8, MIG, IP-10, I-TAC, GRO-a), mediators of hematopoiesis such as M-CSF, antiinflammatory cytokines such as TGF-b and mediators of activation, proliferation, and differentiation of adaptive lymphocytes such as IL-2 and IL-7. Semen-to-blood cytokine ratios observed in our study were generally comparable to those previously reported [8, 9, 12] . This enrichment of cytokines/chemokines in semen establishes a favorable immunologic milieu for fertilization in the female genital tract (i.e. TGF-b) [11, 22] and is likely involved in the maturation and proliferation of leukocytes and in their recruitment to the sites of inflammation [7, 9] . In particular, irrespective from HIV-1 infection, the levels of all three CX chemokine receptor 3 ligands (MIG, IP-10, and I-TAC) as well as the concentrations of IL-7 in semen are 1000 to 10 000 higher than the concentrations in blood plasma. As IL-7 is a central regulator of naive and memory T-cell homeostasis [23] and CXCR3 regulates chemotaxis and effector functions of Th1-type CD4 þ T cells and effector CD8 þ T cells [24, 25] , our findings further indicate that the male genital tract is populated with highly specialized resident T cells maintaining a constitutive state of immune activation in a mucosal compartment that is naturally exposed to sexually transmitted microbes, including HIV-1.
In HIV-1-infected individuals, the concentrations of most cytokines remained statistically different between semen and blood [8, 9] . However, we delineate for the first time specific patterns of modulation of cytokines/chemokines in blood and semen at the different stage of HIV-1 infection and upon initiation of ART. The concentration of five of the 31 measured cytokines was upregulated in the blood of HIV-1-infected individuals in the earliest phase of HIV infection (<90 days from infection) compared with healthy uninfected individuals. These cytokines were all mediators of innate immunity, inflammation or chemokines. Specifically, acute HIV-1 infection-induced upregulation of all three CXCR3 ligands (MIG, IP-10 and ITAC), a CC chemokine receptor 5 (CCR5) ligand (MIP-1a) and the CCR2 ligand (MCP-1). As mentioned earlier, CXCR3 is crucial for the trafficking of Th1 CD4 þ and effector CD8 þ T cells to peripheral sites of inflammation and for the development of Th1 amplification loop mediated by IFNg and the IFNg-inducible CXCR3 ligands (MIG, IP-10 and ITAC). Similarly, CCR5 and CCR2 are involved in chemotaxis of monocytes and T cells. Therefore, although blood plasma levels may only partially reflect changes in peripheral sites, our data may reflect the intense mobilization of the innate and adaptive immune response in an attempt to control acute HIV-1 infection.
In HIV-1-infected individuals in a later stage of the disease, the same five cytokines and additionally IL-18, another potent pro-inflammatory cytokine involved in bridging innate with adaptive immunity [26] , were upregulated in blood. Such observations suggest that the impact of HIV-1 infection on the immunological landscape (reflected by the cytokines in blood plasma) appears quantitatively and qualitative similar independently from the estimated time of infection during active viral replication.
In semen, HIV-1 infection was associated with lower levels of IL-1a, IL-1b, TGF-b and IL-15 in the early phase of infection. Such changes were modest and the most prominent were represented by downregulation of cytokines of the interleukin-1 family (IL-1a, IL-1b, downregulated 2-3 times). Therefore, acute HIV-1 infection does not appear to dramatically perturb the immunological homeostasis in the male genital tract. In the later phase of HIV-1 infection (> 90 days), higher levels of a few pro-inflammatory cytokines were observed in seminal plasma compared with uninfected controls. Some pro-inflammatory markers, such as IL-7, IL-22, MIP-1a, RANTES, eotaxin, MIP-3a, MIG, I-TAC and TNF-a were also upregulated in late phase of HIV-1 infection compared with HIV-uninfected subjects, although they did not reach statistical differences. A significant change was related to the IL-12/IFN-g axis with an upregulation of IFN-g and IL-12 up to 30 and nine fold, respectively. IL-12 produced by antigen presenting cells induces T-cell differentiation and proliferation and IFN-g secretion from activated T cells. Such changes may represent an attempt of the immune system to restore homeostasis in the genital compartment that could be greatly impacted by HIV-1 infection of immune cells of the male genital tract.
Our analysis indicates that an altered cytokine network is evident in blood and in semen from the earliest phase of HIV infection [27] . In blood, an intense pro-inflammatory reaction, reflecting the activation of both innate and adaptive immune systems was developed shortly after HIV-1 infection and further amplified thereafter. In semen, significant changes were apparent only at later time and were qualitatively very different from the blood plasma and initially limited only to a strong activation of the IL-12/IFN-g axis.
Furthermore, in blood plasma, despite complete suppression of HIV-1 replication, we found that ART treatment did not normalize cytokines to levels comparable to that of uninfected subjects. The reports on the effect of ART on blood plasma cytokine level in the literature are somehow conflicting: Haissman et al. [28] showed that 4 months after ART initiation, TNF-a, IL-1RA and IL-6 concentrations were significantly reduced and similar to those found in the uninfected group. However, other studies reported that chemokines and proinflammatory cytokines failed to return to the levels observed in uninfected individuals upon ART initiation [9, 29, 30] . In our study, we found that not only proinflammatory blood cytokines did not return to levels observed in uninfected controls, but rather were further modulated, suggesting further mobilization of the innate immune system (IL-8, eotaxin, MIP-3a and lactoferrin) or impairment of lymphocytes homeostasis (IL-15 and IL-16).
In semen, suppressive ART had even more profound effects: In contrast to the modest changes observed in levels of few cytokines in naïve early or late HIV-1 infected individuals compared with the uninfected group, upon suppression of viral replication in blood by ART, 12 cytokines were largely different compared with uninfected controls. These changes included mostly upregulation of cytokines of all functional groups including a striking upregulation of IL-22 ($ 40-fold increase). IL-22 is a cytokine produced by numerous lymphocytes, such as Th17, Th22, and mucosal associated invariant T cells with regenerative properties for mucosal epithelium. Th17 and Th22 depletion in the gut mucosa is an important feature of HIV mucosal immunopathogenesis that is reversed after ART [31, 32] . We speculate here that such dramatic upregulation in the semen of ART-treated individuals may reflect a repair of mucosal damage and repopulation of IL-22-producing cells in the male genital tract. Overall, despite complete suppression of plasma viremia with ART, we observed significant perturbations in the levels of cytokines associated with the function of the immune cells in the genital tract with possible consequence in the viral and transmission dynamics of HIV-1 as well as other local pathogens.
There are a number of limitations to the current study. Our analysis compared cross-sectional time points from different cohorts while longitudinal data collected from the same individuals during different stages of HIV infection would be preferred to study the complex association between clinical variables and biomarkers. Comparisons between group 2 (early) and group 3 (late) were limited by a relatively small difference in the EDI. Also, treated individuals started ART during the chronic phase of HIV-infection. Future studies should evaluate the impact of early ART initiation on the cytokine network. Lastly, the sample size limited power in discerning a significant effect in subgroups of untreated and ART-naive acutely infected individuals. Additionally, only five participants were positive for chlamydia or gonorrhea. This limited number of cases did not allow us to perform comparisons between participants with and without bacterial STI. However, there was no significant changes in the cytokine's levels in blood and semen for the overall comparisons when eliminating these five participants.
In summary, despite these listed limitations, our study highlights the role of HIV-1 infection and ART treatment in the modulation of cytokine/chemokine networks in blood and in semen. We found that profound changes in the cytokine profile and therefore in the coordination of complex immune functions are established very early upon HIV-1 infection. These changes are maintained throughout the chronic phase of the infection and are not reverted despite ART and full suppression of HIV-1 plasma replication. These changes are likely to be reflected in an altered ability of the innate and adaptive immune response of the male genital tract to maintain immunological homeostasis and prevent the acquisition and transmission of HIV-1 and other STIs. More research is needed to understand the interplays between pathogens and immune response, which could provide important information in the development of effective prevention strategies and complementary therapies to restore the failing immune system during HIV infection.
